Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for GMED

Stock NameGlobus Medical
TickerGMED(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS3795772082
LEI5299003M2P4CIK0RF205

Show aggregate GMED holdings

News associated with GMED

Brokerages Set Globus Medical, Inc. (NYSE:GMED) PT at $87.64
Shares of Globus Medical, Inc. (NYSE:GMED – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average […] - 2025-09-22 02:58:55
Globus Medical, Inc. (NYSE:GMED) Holdings Decreased by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System trimmed its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 18.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,232 shares of the medical device company’s stock after selling 1,163 shares during the quarter. Maryland […] - 2025-08-17 05:16:58
Mitsubishi UFJ Asset Management Co. Ltd. Increases Stock Position in Globus Medical, Inc. (NYSE:GMED)
Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 4.4% during the first quarter, HoldingsChannel reports. The firm owned 8,440 shares of the medical device company’s stock after buying an additional 355 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Globus Medical […] - 2025-08-14 05:27:14
Vanguard Group Inc. Purchases 45,248 Shares of Globus Medical, Inc. (NYSE:GMED)
Vanguard Group Inc. increased its position in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 0.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,909,082 shares of the medical device company’s stock after acquiring an additional 45,248 shares during the period. […] - 2025-08-13 05:43:02
Globus Medical (NYSE:GMED) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Globus Medical (NYSE:GMED – Free Report) from a hold rating to a buy rating in a research report released on Saturday morning. Several other equities research analysts also recently weighed in on the company. Truist Financial cut their price target on Globus Medical from $80.00 to $68.00 and set […] - 2025-08-12 04:16:56
Globus Medical, Inc. (NYSE:GMED) Shares Sold by Choreo LLC
Choreo LLC decreased its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 39.8% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,591 shares of the medical device company’s stock after selling 3,693 shares during the quarter. Choreo LLC’s holdings in […] - 2025-07-29 05:00:54
HighPoint Advisor Group LLC Sells 325 Shares of Globus Medical, Inc. (NYSE:GMED)
HighPoint Advisor Group LLC cut its holdings in Globus Medical, Inc. (NYSE:GMED – Free Report) by 7.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,121 shares of the medical device company’s stock after selling 325 shares during the quarter. HighPoint […] - 2025-07-24 06:28:56
Needham & Company LLC Reiterates “Hold” Rating for Globus Medical (NYSE:GMED)
Needham & Company LLC reissued their hold rating on shares of Globus Medical (NYSE:GMED – Free Report) in a report issued on Monday morning,Benzinga reports. Several other equities research analysts have also issued reports on the stock. BTIG Research restated a “neutral” rating on shares of Globus Medical in a research note on Tuesday, May […] - 2025-07-22 07:13:04
M&T Bank Corp Sells 5,218 Shares of Globus Medical, Inc. (NYSE:GMED)
M&T Bank Corp cut its holdings in Globus Medical, Inc. (NYSE:GMED – Free Report) by 51.8% during the first quarter, Holdings Channel reports. The firm owned 4,849 shares of the medical device company’s stock after selling 5,218 shares during the quarter. M&T Bank Corp’s holdings in Globus Medical were worth $355,000 at the end of […] - 2025-07-18 04:36:53
Mutual of America Capital Management LLC Reduces Holdings in Globus Medical, Inc. (NYSE:GMED)
Mutual of America Capital Management LLC trimmed its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 2.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,538 shares of the medical device company’s stock after selling […] - 2025-07-17 06:09:47
Bank of New York Mellon Corp Has $85.19 Million Stake in Globus Medical, Inc. (NYSE:GMED)
Bank of New York Mellon Corp lowered its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 14.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,163,834 shares of the medical device company’s stock after selling 189,797 […] - 2025-07-11 06:44:57
Globus Medical, Inc. (NYSE:GMED) Shares Acquired by Principal Financial Group Inc.
Principal Financial Group Inc. lifted its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 0.4% during the 1st quarter, Holdings Channel.com reports. The firm owned 261,592 shares of the medical device company’s stock after acquiring an additional 919 shares during the period. Principal Financial Group Inc.’s holdings in Globus Medical were […] - 2025-07-11 05:30:56
Allspring Global Investments Holdings LLC Purchases New Holdings in Globus Medical, Inc. (NYSE:GMED)
Allspring Global Investments Holdings LLC acquired a new position in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) during the 1st quarter, Holdings Channel reports. The firm acquired 10,265 shares of the medical device company’s stock, valued at approximately $753,000. Several other hedge funds and other institutional investors also recently bought and sold shares […] - 2025-07-10 04:36:51
Teacher Retirement System of Texas Sells 9,724 Shares of Globus Medical, Inc. (NYSE:GMED)
Teacher Retirement System of Texas decreased its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 16.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 47,748 shares of the medical device company’s stock after selling 9,724 shares during the […] - 2025-07-09 05:32:57
First Horizon Advisors Inc. Has $64,000 Stock Position in Globus Medical, Inc. (NYSE:GMED)
First Horizon Advisors Inc. raised its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 30.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 872 shares of the medical device company’s stock after purchasing an additional 206 shares during the quarter. […] - 2025-07-08 05:04:46
8,021 Shares in Globus Medical, Inc. (NYSE:GMED) Purchased by Illinois Municipal Retirement Fund
Illinois Municipal Retirement Fund acquired a new position in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) in the 1st quarter, Holdings Channel reports. The fund acquired 8,021 shares of the medical device company’s stock, valued at approximately $587,000. Several other large investors have also made changes to their positions in GMED. Proficio Capital […] - 2025-07-04 04:44:48
KBC Group NV Raises Stake in Globus Medical, Inc. (NYSE:GMED)
KBC Group NV grew its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 47,009 shares of the medical device company’s stock after acquiring an additional 826 shares during the […] - 2025-07-03 05:40:54
Diversified Trust Co Has $887,000 Position in Globus Medical, Inc. (NYSE:GMED)
Diversified Trust Co decreased its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 5.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,110 shares of the medical device company’s stock after selling 701 shares during the period. Diversified Trust […] - 2025-06-30 05:10:56
Oppenheimer Asset Management Inc. Has $1.91 Million Holdings in Globus Medical, Inc. (NYSE:GMED)
Oppenheimer Asset Management Inc. raised its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 8.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,097 shares of the medical device company’s stock after purchasing an additional 2,103 shares during […] - 2025-06-27 05:05:02
State of Alaska Department of Revenue Acquires 350 Shares of Globus Medical, Inc. (NYSE:GMED)
State of Alaska Department of Revenue boosted its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 2.7% in the 1st quarter, Holdings Channel reports. The firm owned 13,320 shares of the medical device company’s stock after buying an additional 350 shares during the quarter. State of Alaska Department of Revenue’s holdings in Globus […] - 2025-06-27 04:32:53
Globus Medical, Inc. (NYSE:GMED) Shares Sold by Johnson Investment Counsel Inc.
Johnson Investment Counsel Inc. lowered its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 14.7% during the first quarter, HoldingsChannel reports. The firm owned 3,341 shares of the medical device company’s stock after selling 577 shares during the quarter. Johnson Investment Counsel Inc.’s holdings in Globus Medical were worth $245,000 as of its […] - 2025-06-23 04:56:57
Parallel Advisors LLC Raises Stock Holdings in Globus Medical, Inc. (NYSE:GMED)
Parallel Advisors LLC lifted its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 62.1% in the first quarter, Holdings Channel reports. The firm owned 504 shares of the medical device company’s stock after buying an additional 193 shares during the period. Parallel Advisors LLC’s holdings in Globus Medical were worth $37,000 at the […] - 2025-06-10 04:48:50
Versant Capital Management Inc Acquires 494 Shares of Globus Medical, Inc. (NYSE:GMED)
Versant Capital Management Inc increased its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 932.1% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 547 shares of the medical device company’s stock after acquiring an additional 494 shares during the quarter. […] - 2025-06-06 05:45:06
JMP Securities Reiterates Market Perform Rating for Globus Medical (NYSE:GMED)
Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “market perform” rating reissued by analysts at JMP Securities in a research note issued to investors on Tuesday,Benzinga reports. GMED has been the topic of several other research reports. Piper Sandler decreased their price objective on Globus Medical from $100.00 to $80.00 and set an […] - 2025-05-29 03:02:55
BTIG Research Reiterates “Neutral” Rating for Globus Medical (NYSE:GMED)
Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “neutral” rating restated by analysts at BTIG Research in a research report issued on Tuesday, Marketbeat Ratings reports. Several other analysts have also weighed in on the company. Stifel Nicolaus upped their target price on Globus Medical from $92.00 to $94.00 and gave the company […] - 2025-05-29 02:15:09
Globus Medical, Inc. (NYSE:GMED) Shares Purchased by ProShare Advisors LLC
ProShare Advisors LLC grew its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 6.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,514 shares of the medical device company’s stock after acquiring an additional 321 shares during the […] - 2025-05-27 05:07:07
Quantinno Capital Management LP Has $387,000 Stock Holdings in Globus Medical, Inc. (NYSE:GMED)
Quantinno Capital Management LP grew its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 20.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,673 shares of the medical device company’s stock after purchasing an additional 784 shares during the period. Quantinno Capital […] - 2025-05-26 04:58:54
Cetera Investment Advisers Boosts Holdings in Globus Medical, Inc. (NYSE:GMED)
Cetera Investment Advisers raised its holdings in Globus Medical, Inc. (NYSE:GMED – Free Report) by 13.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,263 shares of the medical device company’s stock after buying an additional 1,008 shares during the quarter. Cetera Investment […] - 2025-05-26 04:21:03
Deutsche Bank AG Has $3.18 Million Stock Holdings in Globus Medical, Inc. (NYSE:GMED)
Deutsche Bank AG boosted its holdings in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 3.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 38,441 shares of the medical device company’s stock after buying an additional 1,157 shares during the quarter. […] - 2025-05-21 04:42:56
Globus Medical (NYSE:GMED) to Repurchase $500.00 million in Outstanding Stock
Globus Medical (NYSE:GMED – Get Free Report) announced that its Board of Directors has approved a stock buyback plan on Thursday, May 15th, RTT News reports. The company plans to buyback $500.00 million in outstanding shares. This buyback authorization permits the medical device company to purchase up to 6.3% of its shares through open market […] - 2025-05-16 02:10:45

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc GMED holdings

DateNumber of GMED Shares HeldBase Market Value of GMED SharesLocal Market Value of GMED SharesChange in GMED Shares HeldChange in GMED Base ValueCurrent Price per GMED Share HeldPrevious Price per GMED Share Held
2025-09-26 (Friday)12,394USD 690,346USD 690,346
2025-09-25 (Thursday)12,394USD 682,909GMED holding decreased by -2479USD 682,9090USD -2,479 USD 55.1 USD 55.3
2025-09-24 (Wednesday)12,394USD 685,388USD 685,388
2025-09-17 (Wednesday)12,314USD 692,293GMED holding decreased by -19949USD 692,2930USD -19,949 USD 56.22 USD 57.84
2025-09-16 (Tuesday)12,314USD 712,242USD 712,242
2025-09-12 (Friday)12,234USD 718,625USD 718,625
2025-09-11 (Thursday)12,234USD 729,391USD 729,391
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of GMED by Blackrock for IE00B3VWM098

Show aggregate share trades of GMED

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-40 60.500* 71.63 Profit of 2,865 on sale
2025-07-31BUY120 52.630* 71.81
2025-06-30SELL-80 59.020* 73.82 Profit of 5,905 on sale
2025-06-25SELL-40 58.190* 74.14 Profit of 2,966 on sale
2025-06-20SELL-80 57.870* 74.48 Profit of 5,959 on sale
2025-05-23BUY40 58.960* 77.01
2025-05-19SELL-40 61.050* 77.59 Profit of 3,104 on sale
2025-05-15SELL-120 57.820* 77.91 Profit of 9,349 on sale
2025-05-12SELL-80 59.010* 78.44 Profit of 6,275 on sale
2025-04-30SELL-40 71.770* 79.14 Profit of 3,165 on sale
2025-04-24SELL-80 73.070* 79.40 Profit of 6,352 on sale
2025-04-17SELL-40 71.010* 79.86 Profit of 3,194 on sale
2025-04-15SELL-120 72.350* 80.04 Profit of 9,604 on sale
2025-04-14SELL-120 72.980* 80.11 Profit of 9,614 on sale
2025-04-09SELL-160 74.280* 80.37 Profit of 12,859 on sale
2025-04-07SELL-280 70.750* 80.62 Profit of 22,573 on sale
2025-04-04SELL-400 68.830* 80.76 Profit of 32,303 on sale
2025-03-31BUY40 73.200* 81.00
2025-03-19SELL-80 73.340* 81.73 Profit of 6,539 on sale
2025-03-14SELL-240 71.040* 82.16 Profit of 19,719 on sale
2025-03-13SELL-80 69.680* 82.34 Profit of 6,587 on sale
2025-03-12SELL-1,360 71.300* 82.50 Profit of 112,199 on sale
2025-03-07SELL-80 77.410* 82.82 Profit of 6,626 on sale
2025-03-06SELL-120 76.310* 82.92 Profit of 9,950 on sale
2025-03-03SELL-40 79.250* 83.12 Profit of 3,325 on sale
2025-02-28SELL-240 80.320* 83.17 Profit of 19,961 on sale
2025-02-26SELL-40 80.010* 83.30 Profit of 3,332 on sale
2025-02-25SELL-120 79.580* 83.36 Profit of 10,004 on sale
2025-02-18BUY200 84.830* 83.43
2025-02-13BUY40 84.130* 83.39
2025-02-12BUY40 84.010* 83.38
2025-02-11BUY120 84.280* 83.36
2025-02-06BUY360 87.950* 83.08
2025-01-27BUY40 91.980* 81.02
2024-12-30BUY200 82.670* 80.24
2024-12-06BUY160 83.320* 79.96
2024-12-05BUY40 83.090* 79.85
2024-12-04BUY200 84.410* 79.69
2024-11-29BUY200 85.610* 79.07
2024-11-27BUY160 85.290* 78.53
2024-11-26BUY40 84.530* 78.26
2024-11-25SELL-1,344 84.490* 77.96 Profit of 104,778 on sale
2024-11-21BUY220 84.910* 77.24
2024-11-20BUY132 83.590* 76.88
2024-11-18BUY528 81.830* 76.17
2024-11-12BUY352 83.420* 75.69
2024-11-08BUY220 80.880* 75.32
2024-11-07BUY660 81.970* 74.81
2024-11-06BUY88 82.710* 74.15
2024-10-31BUY44 73.540* 73.88
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GMED

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19179,91215,128502,38735.8%
2025-09-18253,42479672,01737.7%
2025-09-17170,5540617,52327.6%
2025-09-16258,270104347,53074.3%
2025-09-15319,4040508,75562.8%
2025-09-12205,394450283,60472.4%
2025-09-11217,1701,600363,40759.8%
2025-09-10328,746300442,98874.2%
2025-09-09231,8800339,63768.3%
2025-09-08219,5180266,16382.5%
2025-09-05342,3240415,88882.3%
2025-09-04454,2030587,94077.3%
2025-09-03339,3420509,44366.6%
2025-09-02291,2745359,25481.1%
2025-08-29203,1640298,73968.0%
2025-08-28167,5430265,02263.2%
2025-08-27203,95180270,41575.4%
2025-08-26257,077109308,77883.3%
2025-08-25313,0660383,55681.6%
2025-08-22187,4780237,61278.9%
2025-08-21152,7950222,80168.6%
2025-08-20201,9131,061320,18363.1%
2025-08-19343,5230486,77270.6%
2025-08-18251,7690560,11644.9%
2025-08-15233,3120464,39050.2%
2025-08-14369,7190517,97771.4%
2025-08-13336,325100514,52965.4%
2025-08-12607,60511871,25869.7%
2025-08-11521,32625720,92972.3%
2025-08-081,002,778551,570,58763.8%
2025-08-07350,07243945,91037.0%
2025-08-06169,11215287,71158.8%
2025-08-05214,165150448,49947.8%
2025-08-04189,63048383,03349.5%
2025-08-01354,38330711,92749.8%
2025-07-31198,231448498,77239.7%
2025-07-30223,7350480,21146.6%
2025-07-29218,799123420,93452.0%
2025-07-28238,2650469,42650.8%
2025-07-25244,77973606,20640.4%
2025-07-24260,910121398,38365.5%
2025-07-23359,450271547,95565.6%
2025-07-22432,3315,2711,091,16839.6%
2025-07-211,053,4332442,499,23242.2%
2025-07-18160,9950290,86555.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.